GABRA2, gamma-aminobutyric acid type A receptor subunit alpha2, 2555
N. diseases: 60; N. variants: 13
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
4 | 46398314 | intron variant | A/G | snv | 0.63 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
1.000 | 0.040 | 4 | 46395600 | intron variant | C/T | snv | 0.22 |
|
Nervous System Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 4 | 46412095 | intron variant | G/A | snv | 1.3E-03 |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
4 | 46337053 | intron variant | T/A | snv | 0.38 |
|
0.700 | 0 | |||||||||||||
|
1.000 | 0.080 | 4 | 46327706 | intron variant | T/A | snv | 0.41 |
|
0.700 | 0 | |||||||||||
|
0.882 | 0.080 | 4 | 46303716 | intron variant | T/C | snv | 0.38 |
|
0.700 | 0 | |||||||||||
|
0.851 | 0.080 | 4 | 46312576 | synonymous variant | T/C | snv | 0.40 | 0.38 |
|
Chemically-Induced Disorders; Mental Disorders | 0.050 | 1.000 | 5 | 2012 | 2016 | ||||||
|
0.882 | 0.080 | 4 | 46303716 | intron variant | T/C | snv | 0.38 |
|
Chemically-Induced Disorders; Mental Disorders | 0.040 | 0.750 | 4 | 2010 | 2017 | |||||||
|
0.882 | 0.080 | 4 | 46303716 | intron variant | T/C | snv | 0.38 |
|
Mental Disorders | 0.020 | 0.500 | 2 | 2010 | 2017 | |||||||
|
0.925 | 0.080 | 4 | 46369816 | intron variant | G/A;T | snv |
|
Chemically-Induced Disorders; Mental Disorders | 0.020 | 0.500 | 2 | 2014 | 2015 | ||||||||
|
1.000 | 0.080 | 4 | 46388848 | 5 prime UTR variant | C/G | snv | 0.27 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.080 | 4 | 46388848 | 5 prime UTR variant | C/G | snv | 0.27 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.080 | 4 | 46270789 | intron variant | G/A | snv | 7.6E-02 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 4 | 46270789 | intron variant | G/A | snv | 7.6E-02 |
|
Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 4 | 46332192 | intron variant | A/G | snv | 0.46 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.080 | 4 | 46332192 | intron variant | A/G | snv | 0.46 |
|
0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.080 | 4 | 46332192 | intron variant | A/G | snv | 0.46 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 4 | 46332192 | intron variant | A/G | snv | 0.46 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
4 | 46332685 | splice region variant | A/G;T | snv | 0.44 | 0.41 |
|
0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
4 | 46332685 | splice region variant | A/G;T | snv | 0.44 | 0.41 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.080 | 4 | 46327706 | intron variant | T/A | snv | 0.41 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.080 | 4 | 46312576 | synonymous variant | T/C | snv | 0.40 | 0.38 |
|
0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.080 | 4 | 46312576 | synonymous variant | T/C | snv | 0.40 | 0.38 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.851 | 0.080 | 4 | 46312576 | synonymous variant | T/C | snv | 0.40 | 0.38 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.851 | 0.080 | 4 | 46312576 | synonymous variant | T/C | snv | 0.40 | 0.38 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 |